Latest filing published 31 May 2019 for A1M Pharma AB, €1,941.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Gunnar Telhammar: trading record in brief
Gunnar Telhammar discloses dealings in A1M Pharma AB to Finansinspektionen. In total, 4 filings cover trades dated from 15 February 2019 to 31 May 2019.
Every open-market trade on record is a purchase: 3 purchases worth €2,095, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The median purchase comes to €137.
The record was last updated on 31 May 2019 with an open-market purchase (€1,941) in A1M Pharma AB. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Gunnar Telhammar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ SEK 1.0348.1% of flowAktieISIN SE0009973357FI:csv-51eb1ab8eac203f0614eCanonical exit: 29 Aug 2019 (T+90)
- 6,000 shares@ SEK 0.030.4% of flowTeckningsrättISIN SE0012230712FI:csv-e556f95257679b85557bCanonical exit: 16 May 2019 (T+90)
- 2,000 shares@ SEK 10.2048.1% of flowBTU (betald tecknad unit)ISIN SE0012230720FI:csv-de52d1f35e914d95c09b
- 141 shares@ SEK 10.203.4% of flowBTU (betald tecknad unit)ISIN SE0012230720FI:csv-792543f1912ee87861f9Canonical exit: 16 May 2019 (T+90)
4 of 4 declarations